FDA Can't Revoke Ranbaxy's Drug Approvals, DC Circ. Told
Ranbaxy Inc. has asked the D.C. Circuit to overturn a federal court's upholding of a "historically unprecedented" decision by the U.S. Food and Drug Administration to strip the pharmaceutical giant of...To view the full article, register now.
Already a subscriber? Click here to view full article